Physician

Donald Jin Sonn, M.D.

According to 2025 Medicare claims, Donald Sonn, M.D. (NPI: 1821078296) practices urology in the Amherst Town-Northampton, MA market, with the plurality of this provider's patient population coming from Hampshire, MA. This provider's primary affiliated billing organization is UROLOGY GROUP OF WESTERN NEW ENGLAND, P.C. (NPI: 1730263039; TIN: 042499982) and primary practice location at 01060-2546.

Sonn's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,062 traditional Medicare patients, billed 7,926 HCPCS/CPT codes, and received $489,913 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 980 prescription claims across 410 beneficiaries totaling $211,230 in drug costs, led by Orgovyx (Relugolix). DME data shows 295 claims. Open Payments data shows 15 records totaling $792. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $86,981 and ending at $211,230. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $1,263 to $1,022.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,090	4,915	$346,990
2016	1,160	6,219	$407,952
2017	1,305	6,275	$451,691
2018	1,200	5,586	$399,914
2019	1,247	7,132	$407,553
2020	980	8,133	$391,223
2021	1,014	7,874	$483,363
2022	982	7,981	$495,130
2023	1,048	8,105	$435,268
2024	1,062	7,926	$489,913

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	277	761	$86,981
2016	368	1,066	$124,949
2017	394	960	$103,885
2018	422	1,268	$160,520
2019	411	1,083	$135,578
2020	372	856	$87,020
2021	385	930	$64,412
2022	367	870	$95,228
2023	371	806	$104,710
2024	410	980	$211,230

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	40	$5,253
2016	N/R	127	$13,692
2017	N/R	119	$9,757
2018	37	328	$9,376
2019	36	339	$14,723
2020	33	313	$17,025
2021	12	307	$31,186
2022	25	369	$54,257
2023	24	414	$53,252
2024	14	295	$51,949

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	596	863	$99
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	283	307	$68
51798	Ultrasound measurement of bladder capacity after voiding	327	395	$9
81001	Manual urinalysis test with examination using microscope, automated	280	395	$3
81003	Automated urinalysis test	536	668	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Orgovyx	Relugolix	31	930	$84,391
Gemtesa	Vibegron	64	3,865	$60,606
Myrbetriq	Mirabegron	32	1,620	$24,144
Tamsulosin Hcl	Tamsulosin Hcl	344	27,152	$7,069
Alfuzosin Hcl Er	Alfuzosin Hcl	83	6,810	$2,716

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	32	$25,231
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	29	$8,083
A4409	Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, 4 x 4 inches or smaller, each	N	N/R	35	$8,009
A4432	Ostomy pouch, urinary; for use on barrier with non-locking flange, with faucet-type tap with valve (2 piece), each	N	N/R	33	$4,469
A4385	Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each	N	N/R	12	$3,160

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	15	$792	PROCEPT BioRobotics Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Donald Jin Sonn, M.D.?

Tedicare shows public-source Medicare data for Donald Jin Sonn, M.D. (NPI 1821078296), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Donald Jin Sonn, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Donald Jin Sonn, M.D.?

Donald Jin Sonn, M.D. is linked to UROLOGY GROUP OF WESTERN NEW ENGLAND, P.C. (billing NPI 1730263039) in the available physician profile data.

Does Donald Jin Sonn, M.D. have Open Payments data?

Donald Jin Sonn, M.D. has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.